Category Specific RSS

News

Cann Group praying to recover $3.6m lost to internet scammers

In an incident which can only be described with a šŸ¤¦ā€ā™‚ļø, shareholders of cannabis company Cann Group (ASX: CAN) are understandably frustrated in the Company which has reported a cybersecurity breach that resulted in $3.6 million going missing.Ā 

The incident was discovered on 4 February and immediately led Cann to enter a trading halt as the Company scrambled to understand why payments made to an overseas contractor were not received.Ā 

As reported by Cann’s ASX release, ā€œthose payments have been received by an unknown third party as a result of a complex and sophisticated cyber fraud perpetrated against the Company and its overseas contractor.ā€Ā 

While Cann has funds to continue its day-to-day operations, the Company is working with its bank in an effort to recoup the $3.6m and has notified its insurance brokers hoping the funds can be recovered as a claim if the bank is unsuccessful.Ā 

Cann Group has not disclosed exactly how the $3.6m was sent to an unknown account but common online scams that normally target individuals commonly take place when scammers alter the bank details on invoices. In those instances, funds are rarely recovered from banks as scammers withdraw them immediately.

Cann has engaged external security and forensic IT experts to assist on the incident and notified authorities in Australia, the Netherlands and Hong Kong.Ā 

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSenseĀ® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSenseĀ® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray LenzettoĀ® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago